Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia

Rosenkranz, 1983, Myocardial protection during surgical coronary reperfusion, J Am Coll Cardiol, 1, 1235, 10.1016/S0735-1097(83)80135-1 Preckel, 1998, Effects of enflurane, isoflurane, sevoflurane, and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo, Br J Anaesth, 81, 905, 10.1093/bja/81.6.905 Schlack, 1997, Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo, Br J Anaesth, 79, 88, 10.1093/bja/79.1.88 Schlack, 1998, Effects of halothane, enflurane, isoflurane, sevoflurane, and desflurane on myocardial reperfusion injury in the isolated rat heart, Br J Anaesth, 81, 913, 10.1093/bja/81.6.913 Preckel, 1998, Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart, Anesth Analg, 87, 1221, 10.1213/00000539-199812000-00001 Preckel, 1999, Beneficial effects of sevoflurane and desflurane against myocardial reperfusion injury after cardioplegic arrest, Can J Anaesth, 46, 1076, 10.1007/BF03013206 Crawford, 1992, Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation, Anesth Analg, 75, 1000, 10.1213/00000539-199212000-00021 Hearse, 1981, The working heart preparation, 59 Demertzis, 1993, University of Wisconsin versus St Thomas’ Hospital solution for human donor heart preservation, Ann Thorac Surg, 55, 1131, 10.1016/0003-4975(93)90019-E Gott, 1990, Cardioplegia for transplantation: failure of extracellular solution compared with Stanford or UW solution, Ann Thorac Surg, 50, 348, 10.1016/0003-4975(90)90473-J Ledingham, 1990, Prolonged cardiac preservation. Evaluation of the University of Wisconsin preservation solution by comparison with the St Thomas’ Hospital cardioplegic solutions in the rat, Circulation, 82, IV351 Yeh, 1990, Superior myocardial preservation with modified UW solution after prolonged ischemia in the rat heart, Ann Thorac Surg, 49, 932, 10.1016/0003-4975(90)90869-8 Rosenfeldt, 1996, Comparison of UW solution and St. Thomas’ solution in the rat: importance of potassium concentration, Ann Thorac Surg, 61, 576, 10.1016/0003-4975(95)01085-8 Mankad, 1992, Endothelial dysfunction caused by University of Wisconsin preservation solution in the rat heart. The importance of temperature, J Thorac Cardiovasc Surg, 104, 1618, 10.1016/S0022-5223(19)33892-9 Siegmund, 1997, Halothane protects cardiomyocytes against reoxygenation‐induced hypercontracture, Circulation, 96, 4372, 10.1161/01.CIR.96.12.4372 Schlack, 1995, Intracoronary SIN‐1C during reperfusion reduces infarct size in dog, J Cardiovasc Pharmacol, 25, 424, 10.1097/00005344-199503000-00012 Siegmund, 1991, Temporary contractile blockade prevents hypercontracture in anoxic‐reoxygenated cardiomyocytes, Am J Physiol, 260, H426 Hara, 2001, Sevoflurane protects stunned myocardium through activation of mitochondrial ATP‐sensitive potassium channels, Anesth Analg, 92, 1139, 10.1097/00000539-200105000-00012 Zaugg, 2000, Norepinephrine‐induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics, Anesthesiology, 93, 209, 10.1097/00000542-200007000-00032 Coetzee, 2000, Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane, Anesth Analg, 90, 1089, 10.1097/00000539-200005000-00016 Obal, 2002, One MAC of sevoflurane already provides protection against reperfusion injury in the rat heart in vivo, Br J Anaesth